Search
1 - 8 of 8 items
Triple Mutation Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719S), 20 (T790M) and 21 (L858R) in a Male Patient with Lung Adenocarcinoma: A Case Report
13-20
Abstract : 1861
PDF : 1320
Survival Analysis of Lung Adenocarcinoma Patients with Exon 19 Del and 21 L858R Mutations Receiving EGFR-TKI Treatment
101-107
Abstract : 527
PDF : 380
Profile of Exon 20 T790M Mutation Incidence Rate with Plasma ctDNA in Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
12-17
Abstract : 717
PDF : 303
Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors
133-139
Abstract : 1224
PDF : 497
EGFR Mutated Lung Adenocarcinoma with Secondary Glaucoma as Early Manifestation: A Case Report
14-18
Abstract : 4386
PDF : 1796
Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer
140-146
Abstract : 123
PDF : 20
Risk Factors and Challenging Management of Lung Adenocarcinoma in Young Adult Women: Case Series
94-98
Abstract : 1039
PDF : 440
1 - 8 of 8 items